Fulcrum Therapeutics (FULC) EBT Margin Growth (1y) (2021 - 2024)
Fulcrum Therapeutics (FULC) EBT Margin Growth (1y) (2021 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Fulcrum Therapeutics |
267.51 Mn |
267.51 Mn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
277,187.00 |
| Dec 31, 2023 |
97,308.00 |
| Sep 30, 2023 |
-115,770.00 |
| Jun 30, 2023 |
-89,231.00 |
| Mar 31, 2023 |
-739,935.00 |
| Dec 31, 2022 |
-335,103.00 |
| Sep 30, 2022 |
-158,682.00 |
| Jun 30, 2022 |
-136,183.00 |
| Mar 31, 2022 |
-64,535.00 |
| Dec 31, 2021 |
-4,489.00 |
| Sep 30, 2021 |
60,631.00 |
| Jun 30, 2021 |
33,577.00 |
| Mar 31, 2021 |
210,531.00 |
